Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Dome Therapeutics
AddedMar 20, 2024
UpdatedJun 18, 2026
Dome Therapeutics

Dome Therapeutics

Angel

Ponte Vedra Beach-based medical organization founded in 2019.

HQ
Ponte Vedra Beach, FL, US
Founded
2019
Overview
Compare
Fundraising
Employees

Dome Therapeutics, founded in 2019 and based in Ponte Vedra Beach, Florida, focuses on innovative medical solutions. The company aims to improve patient outcomes through advanced therapeutic products and services, targeting various healthcare markets.

Since its inception, Dome Therapeutics has made significant strides in the medical field, contributing to enhanced patient care and treatment methodologies. The organization continues to impact the healthcare industry positively through its pioneering efforts.

Dome Therapeutics - Similar Companies

Nomax Therapeutics logo

Nomax Therapeutics

Dose Therapeutics logo

Dose Therapeutics

Santi Therapeutics logo

Santi Therapeutics

Athenen Therapeutics logo

Athenen Therapeutics

Valiant DTX logo

Valiant DTX

Marlinspike Therapeutics logo

Marlinspike Therapeutics

CinDome Pharma logo

CinDome Pharma

cindome.com

Mimosa Therapeutics logo

Mimosa Therapeutics

Nerio Therapeutics logo

Nerio Therapeutics

Advent Therapeutics logo

Advent Therapeutics

Avalor Therapeutics logo

Avalor Therapeutics

avalortx.com

Montara Therapeutics logo

Montara Therapeutics

Arcuate Therapeutics logo

Arcuate Therapeutics

Nepenthea logo

Nepenthea

nepenthes.co.jp

Consortia Therapeutics logo

Consortia Therapeutics

Dome Therapeutics - Quick Facts

Who are Dome Therapeutics' competitors?

Companies similar to Dome Therapeutics include Nomax Therapeutics, Dose Therapeutics, Santi Therapeutics and Athenen Therapeutics.

When was Dome Therapeutics founded?

Dome Therapeutics was founded in 2019.

Where is Dome Therapeutics' headquarters located?

Dome Therapeutics' headquarters is located in Ponte Vedra Beach, FL, US.

When was Dome Therapeutics' last funding round?

Dome Therapeutics' most recent funding round was for $100k (USD) in January 2024.

How much has Dome Therapeutics raised to-date?

As of Jan 15, 2024, Dome Therapeutics has raised a total of $250k (USD).

How many employees does Dome Therapeutics have?

Dome Therapeutics has 50 employees as of Feb 5, 2024.

Dome Therapeutics - Classification

Ownership
  • Private
Technology
  • HealthTech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical
Tags
  • SaaS
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 325000Chemical Manufacturing
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 2830Drugs
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8731Commercial Physical and Biological Research